We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+19.6%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$269M
AUM Growth
+$71.2M
Cap. Flow
+$40.1M
Cap. Flow %
14.87%
Top 10 Hldgs %
31.44%
Holding
57
New
13
Increased
18
Reduced
17
Closed
7

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$7.45M
2
BIIB icon
Biogen
BIIB
+$5.55M
3
AMGN icon
Amgen
AMGN
+$5.51M
4
CNC icon
Centene
CNC
+$5.15M
5
ZBH icon
Zimmer Biomet
ZBH
+$4.98M

Top Sells

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$5.18M
2
BDX icon
Becton Dickinson
BDX
+$5.06M
3
CELG
Celgene Corp
CELG
+$4.96M
4
ALC icon
Alcon
ALC
+$3.15M
5
DGX icon
Quest Diagnostics
DGX
+$2.35M

Sector Composition

Rank Sector Weight
1 Healthcare 98.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
A icon
51
Agilent Technologies
A
$42.2B
– –
-10,000
Closed -$766K
ACAD icon
52
Acadia Pharmaceuticals
ACAD
$5.07B
– –
-40,000
Closed -$1.44M
BDX icon
53
Becton Dickinson
BDX
$49.4B
– –
-20,500
Closed -$5.06M
CHRS icon
54
Coherus Oncology
CHRS
$187M
– –
-45,296
Closed -$918K
TDOC icon
55
Teladoc Health
TDOC
$1.24B
– –
-19,100
Closed -$1.29M
WCG
56
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-20,000
Closed -$5.18M
CELG
57
DELISTED
Celgene Corp
CELG
– –
-50,000
Closed -$4.96M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q4 2019 Portfolio in Review

As of Q4 2019, Sivik Global Healthcare held 57 positions worth $269M, up 36% from $198M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sivik Global Healthcare deployed $40.1M of net new capital in Q4 2019, opening 13 new positions and adding to 18 existing holdings. Its largest new stake was Bristol-Myers Squibb: 130,000 shares worth $8.35M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 96% a quarter earlier.

On the sell side, the largest reduction was Alcon, an estimated $3.15M trimmed.

  • Sivik Global Healthcare's largest Q4 2019 buy was Bristol-Myers Squibb: 130,000 shares worth $8.35M.
  • Sivik Global Healthcare added most to Centene in Q4 2019, an estimated $5.15M increase.
  • Sivik Global Healthcare's biggest Q4 2019 reduction was Alcon, cutting an estimated $3.15M.
  • Sivik Global Healthcare fully exited Wellcare Health Plans, Inc. in Q4 2019, selling an estimated $5.18M.
  • Sivik Global Healthcare's ten largest holdings make up 31% of its $269M portfolio in Q4 2019.
  • Sivik Global Healthcare opened 13 new positions and closed 7 in Q4 2019.
  • Sivik Global Healthcare's portfolio value rose 36% quarter-over-quarter to $269M.

Based on Sivik Global Healthcare's 13F filing for Q4 2019, filed 13 Feb 2020.